BioHarvest Sciences Inc. (Vinia)

www.bioharvest.com ; www.vinia.com

Formerly Canna-V-Cell, Fruitura Bioscience, Hi-Nutra

High-Tech Company
Public Company

(NASDAQ GM: BHST)

TECH VERTICALS

AgriBiotech, Agrifood, AgriTech, Biotechnology, Fitness, FoodTech, Health, Supplements, Wellness

General Data

Sector	Agritech
Company Stage:	Initial Revenues
Established	2007
Number of Employees	18
Reg. Number:	abCDe

DESCRIPTION

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

TECHNOLOGY

Technological platform to grow fruit cell cultures in bioreactors.
VINIA®, Commercial scale production of active ingredients from fruits and plants. Industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself.

	TARGET MARKETS
	Consumer Health Market

	BUSINESS MODEL
	B2B

REMARKS

Date

Remark

BioHarvest LTD. was established in 2007. In October 2018 Dolarin, a fully owned subsidiary of BioHarvest, completed a reverse merger with Midnight Star Ventures Corp., a public company trading on CSE. In the transaction, Midnight Star Ventures acquired all the shares of Dolarin from BioHarvest, in exchange for issuing 50.55% of its shares to BioHarvest. Following the merger, the merged public company changed its name to Canna-V-Cell Sciences Inc. In March 2020 Canna-V-Cell Sciences merged with Bioharvest and the merged public company changed its name to BioHarvest Sciences Inc. In November 2024 BioHarvest Sciences listed on NASDAQ and in February 2025 it delisted from CSE. It remains trading on NASDAQ.

CONTACT INFO

Expand / Collapse All

Main Address: Vancouver, Canada

Address	625 Howe Street Suite 1140
City	Vancouver
Country	Canada
Zip	V6C 2T6

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Rehovot, Israel

Address	3 Pekeris St.
City	Rehovot
Country	Israel
Zip	7670203

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Ilan Sobel	CEO	AB InBev Israel (COO)
Dr. Yochi Hagay	CTO & Co-Founder
Dr. Ilana Belzer	COO	Procognia (VP, R&D & Operations)
Ms. Bar Dichter	CFO
Ms. Michal Sapir-Abargel	VP, Regulatory Affairs
Dr. Malkit Azachi	VP, R&D
Dr. Zaki Rakib	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Executive Chairman	CEO & Co-Founder, BioHarvest
abC Defghij	Board Member	CTO & Co-Founder, BioHarvest
abC Defghij	Board Member	President, BioHarvest
abC Defghij	Board Member	N\A

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Reverse Merger

Oct. 02, 2018

R&D

abCDe

Dolarin, a fully owned subsidiary of BioHarvest, completed a reverse merger with Midnight Star Ventures Corp., a public company trading on CSE. In the transaction, Midnight Star Ventures acquired all the shares of Dolarin from BioHarvest, in exchange for issuing 50.55% of its shares to BioHarvest. Following the merger, the merged public company changed its name to Canna-V-Cell Sciences Inc. In March 2020 Canna-V-Cell Sciences merged with Bioharvest and the merged public company changed its name to BioHarvest Sciences Inc; 02/2015: Delisted from CSE

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Holding Company	abCDe

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Nov. 12, 2024	Listing	NASDAQ GM	abCDe	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Oct. 07, 2020

Initial Revenues

abCDe

PIPE

Sep. 14, 2020

Initial Revenues

abCDe

PIPE

Aug. 06, 2020

Initial Revenues

abCDe

PIPE

Jun. 10, 2020

Initial Revenues

abCDe

PIPE

Apr. 23, 2020

Initial Revenues

abCDe

PIPE

Jan. 01, 2019

Initial Revenues

abCDe

Third Round

Oct. 01, 2014

R&D

abCDe

Second Round

Oct. 01, 2013

R&D

abCDe

First Round

Jul. 15, 2012

R&D

abCDe

Seed

Oct. 01, 2007

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Nov. 01, 2025

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe